Hematopoiesis is maintained by specific interactions between both hematopoietic and non-hematopoietic cells.
Introduction
Mesenchymal stem cells (MSCs) present in bone marrow (BM) are thought to give rise to cells that constitute the hematopoietic microenvironment (HME) 1 . MSCs have been isolated from BM and various tissues from humans and many other species, expanded in culture, and shown to differentiate into osteocytes, chondrocytes, adipocytes, and myoblasts under defined conditions in vitro 2 . In culture, MSCs produce a number of cytokines and extracellular matrix proteins, and express cell adhesion molecules, all of which are involved in the regulation of hematopoiesis 3, 4 . They also support the development of hematopoietic colonies in vitro 4 . However, in contrast to hematopoietic stem cells (HSCs) that have been prospectively isolated and extensively studied at the single cell level both in vitro and in vivo, MSCs have only been defined and isolated by physical and functional properties in vitro. Consequently, little is known about their phenotypic and functional characteristics in vivo.
Systemic administration of MSCs for facilitation of bone marrow transplantation has
been proposed based on the in vitro characteristics of MSCs 5 . In recent studies, cotransplantation of human MSCs and HSCs resulted in increased chimerism or/and accelerated hematopoietic recovery in animal models and in humans [6] [7] [8] [9] , suggesting a role for MSCs in the engraftment and repopulation of HSCs. Although the existence of donor MSCs has been documented in the BM of recipient animals following MSC infusion 9, 10 , the methods used to detect engraftment, such as polymerase chain reaction (PCR) or staining of cytospin samples, could not unambiguously distinguish engraftment from cell survival or non-specific lodgment on the vascular bed. In We employed a dual-color genetic marking strategy 15 along with immunofluorescent staining to distinguish and investigate transplanted cells in situ. We show that transplanted human MSCs integrated into the functional components of the HME, and that these MSC-derived cells appeared to be actively involved in the maintenance of human hematopoiesis in murine BM.
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Materials and methods

Isolation of human cord blood CD34-positive cells (CBCD34)
Human umbilical cord blood samples were obtained from full-term deliveries with informed consent of the mother and used in accordance with the institutional guidelines approved by the Tokai University Committee on Clinical Investigation. CD34-positive cells were selected using the CD34 Progenitor Cell Isolation Kit (Miltenyi Biotec, Sunnyvale, CA) according to the manufacturer's instructions as described previously 12 .
The purity of selected cells (CBCD34) was always more than 95%, and they were cryopreserved until use in liquid nitrogen. In some experiments, CBCD34 were further fractionated into CD34 + CD38 + and CD34 + CD38 -populations at the day of transplantation.
Human MSCs
Human MSCs were purchased from Cambrex Bio Science Walkersville Inc.
(Walkersville, MD) and cultured according to the directions supplied by the company.
The ability to differentiate into adipocytes, chondrocytes and osteoblasts was confirmed in vitro before they were used for the experiments 2 .
Antibodies
The following antibodies were used for tissue immunostaining: anti-CD15 (80H5 Experimental animals, lentiviral gene transduction, and cell transplantation Eight-to ten-week old male NOD/Shi-scid (NOD/SCID) mice were purchased from CLEA JAPAN (Tokyo, Japan) and housed in sterile microisolator cages in the animal facility of Tokai University School of Medicine. Mice were given autoclaved food and water. Twenty-four hours before transplantation, mice were irradiated with 300cGy
from an x-ray irradiator (HW-300, Hitex, Osaka, Japan) and thereafter fed acidified water. All procedures were approved by the Animal Care Committee of Tokai University. Prior to transplantation into mice, MSCs and CBCD34 were genetically marked with eGFP or its yellow variant enhanced yellow fluorescent protein (eYFP).
Transduction of CBCD34 and MSCs was carried out as described previously 15, 16 MSCs into the right tibia and 10 μL of PBS into the left tibia by IBMT, followed by administration of 1X10 6 PKH26-labeled CBCD34 into the retro-orbital plexus.
Twenty hours after transplantation, mice were sacrificed, and BM cells were collected separately from the MSC-and the PBS-injected tibia.
Analysis of human cell engraftment
A total of 1X10 6 MSCs was injected into the right tibia of irradiated NOD/SCID mice, and then 5X10 4 CBCD34 were injected into the retro-orbital plexus of the mice.
Control groups received the same amount of PBS in the right tibia. At 6 weeks after transplantation, mice were sacrificed, and BM cells were collected separately from each tibia. Aliquots of cells were used to examine the percentages of CD45-, CD19-, CD33-, and CD34-expressing cells in the respective tibia. Two-color flow cytometric analysis was conducted using FACSCaliber. Quadrants were set to include at least 97% of the isotype-negative cells. The proportion of each lineage was calculated from 20,000 events acquired using CELLQuest software. Remaining cells were saved for the clonogenic cell assay and secondary transplantation. Tokyo, Japan), and frozen in liquid nitrogen. Frozen sections of decalcified bone were obtained using a cryostat microtome (CM3050, Leica, Germany) and stored at -80°C until staining. Immunofluorescent staining and enzyme immunohistochemistry were performed as described previously 16 . For immunofluorescent analysis, slides were examined using a confocal microscope (LSM510 META, CarlZeiss, Jena, Germany). 
Clonogenic cell assay
Statistical analysis
All values are presented as the mean ± SD. The 2-sided P value was determined, Two other types of eGFP-cells that were negative for α-SM actin were also present in BM: flattened cells located in the hematopoietic cords but not specifically associated with the vasculature ( Figure 3G ); and cells characterized by long cytoplasmic extensions, so-called reticular cells ( Figure 3H ) that are considered to be the predominant cells of the HME 25, 26 . BM was often interspersed with a fine network of cell processes that expressed alkaline phosphatase (ALP; Figure 3I ), an enzyme that Figure 4A ). There were 2-fold more human CD45 + cells in the MSC-injected tibia compared to the noninjected tibia (25.7 ± 17.6% versus 12.8 ± 11.1%, p = 0.002, Figure   4B ), and the absolute number of CD34 + cells present in the MSC-injected tibia  was 3-fold higher than that in the noninjected tibia (99,296 ± 68,189 versus 31,525 ± 25,224, This developmental paradigm, including signaling molecules that regulate stem cell self-renewal 49 , is conserved for generating and maintaining specific tissues in adult life, and dysregulation of this process leads to pathologic conditions such as cancer 50 .
Current empirical cancer studies have focused on identifying intrinsic genetic changes that lead to the aberrant proliferation of cells, and, as a result, therapeutic agents targeting the genetic mutations are emerging. However, our understanding of extrinsic, or microenvironmental, signals in the context of tumorigenesis has lagged behind. As the microenvironment is responsible for homeostatic controls 45, 51, 52 , is there a specific microenvironment that permits, initiates, or complements tumorigenesis and supports progression of tumors? Could the microenvironment be a new target for cancer therapy? The experimental system we described here, which allows the visualization
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and reconstitution of a human microenvironment, provides a unique tool to study the maintenance of tissue homeostasis, which may lead to the elucidation of the tumorigenic microenvironment. In addition, the functional persistence of transplanted MSCs in the host environment means that MSCs may be used to deliver therapeutic genes or agents to target tissues. Fourteen slides from at least 8 different mice were examined to count each cell type. Slides containing 115 ± 19 cells in the diaphyseal shaft were chosen for this analysis. As the endosteal region was arbitrarily decided within 12 cells of both endosteum, the endosteal area comprised approximately 21.4 ± 3.8% of the BM cavity in this study. The proportion of cells located in the endosteal area were calculated for each slide and expressed as the means ± SD. * P < 0.0001 relative to the CD15 and GlyA groups.
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